Antimalarials.
Antimalarial medications have become the parenteral drugs of choice for treating the cutaneous manifestations of lupus erythematosus. The immune-modulating activity of these agents makes them useful in a variety of other dermatoses. With prudent dosage and monitoring, these agents can be used safely and effectively in the treatment and management of dermatologic disease.
Van Beek
M J
MJ
Department of Dermatology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.
Piette
W W
WW
D000962:Antimalarials / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002738:Chloroquine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D011796:Quinacrine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D012871:Skin Diseases / Q000188:drug therapy*
D000962:Antimalarials; D003879:Dermatologic Agents; D002738:Chloroquine; D011796:Quinacrine